How should you manage a pediatric oncology patient who has an ANC > 500 and a normal chest x-ray but is confirmed to be infected with COVID-19 and is immunosuppressed from chemotherapy?
Should the patient be admitted for observation which will risk exposing other immunocompromised patients to COVID-19, or should the patient be quarantined at home where the patient will not have constant monitoring by medical personnel?
Answer from: at Academic Institution
The treatment for pediatric patients with cancer who develop COVID-19 is very poorly defined. The risk of severe disease is unknown because although adults with cancer appear to have worse outcomes than those without, non-immunocompromised children seem to have few severe outcomes from the disease a...
Sign in or Register to read more